FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210372906> ?p ?o ?g. }

• W4210372906 endingPage "271.e13" @default.
• W4210372906 startingPage "271.e1" @default.
• W4210372906 abstract "The number of twin pregnancies continues to increase worldwide as both the number of pregnancies obtained by medically assisted reproduction and age at first pregnancy keep rising. Preterm delivery is the major complication associated with twin pregnancies. The effectiveness of preventive treatments such as progesterone or cervical cerclage for women with a short cervix is doubtful in twin pregnancies. The effectivity of cervical pessaries in preventing preterm birth and its associated morbidity and mortality is also controversial.We sought to investigate if the Arabin pessary reduces adverse neonatal outcomes in twin pregnancies with a short cervix.This open-label, multicenter, randomized controlled trial on twin pregnancies with a cervical length of <35 mm compared pessary placement at 16+0 to 24+0 weeks' gestation with standard care alone. The primary endpoint was a composite of adverse neonatal outcomes, namely peripartum or neonatal death or significant neonatal morbidity before hospital discharge, defined as at least 1 of the following complications: bronchopulmonary dysplasia, intraventricular hemorrhage grade III to IV, periventricular leukomalacia, necrotizing enterocolitis grade II or higher, culture-proven sepsis, and retinopathy requiring treatment. A sample size of 308 pregnancies was planned to ensure 80% power to compare the proportions of women with at least 1 infant with an adverse neonatal outcome. The intention-to-treat analysis after multiple imputation of missing data, was supplemented with a secondary analysis that controlled for gestational age and cervical length, both at inclusion. The primary endpoint was also compared between randomization groups in the per-protocol population, which excluded patients with prespecified major protocol violations (mostly cervical cerclage and/or progesterone after inclusion). Secondary endpoints included preterm birth, spontaneous preterm birth, and pessary side effects.In total, 315 women were randomized to either receive a pessary (n=157) or standard management (n=158). Overall, 10.8% (34 women) of participants had a missing value for the primary endpoint, mostly (79%) because of the lack of paternal consent for neonatal data collection. In the intention-to-treat analysis, the adverse neonatal outcome occurred in 16.8% of the pessary group vs in 22.5% of the control group (risk ratio, 0.69; 95% confidence interval, 0.39-1.23; P=.210). The per-protocol analysis did not show any significant difference between groups (risk ratio, 0.78; 95% confidence interval, 0.47-1.28; P=.320). The occurrence of preterm birth or spontaneous preterm birth did not differ significantly between groups. No serious side effects were associated with pessary use.Pessary use in our study did not significantly reduce adverse neonatal outcomes in twin pregnancies with a short cervix." @default.
• W4210372906 created "2022-02-08" @default.
• W4210372906 creator A5000904276 @default.
• W4210372906 creator A5001650037 @default.
• W4210372906 creator A5006946714 @default.
• W4210372906 creator A5021787063 @default.
• W4210372906 creator A5022386988 @default.
• W4210372906 creator A5029642865 @default.
• W4210372906 creator A5037923520 @default.
• W4210372906 creator A5047407744 @default.
• W4210372906 creator A5048730761 @default.
• W4210372906 creator A5048837610 @default.
• W4210372906 creator A5052004467 @default.
• W4210372906 creator A5052824216 @default.
• W4210372906 creator A5056903822 @default.
• W4210372906 creator A5059256161 @default.
• W4210372906 creator A5059769437 @default.
• W4210372906 creator A5062343791 @default.
• W4210372906 creator A5064528607 @default.
• W4210372906 creator A5073048018 @default.
• W4210372906 creator A5078240991 @default.
• W4210372906 creator A5078408177 @default.
• W4210372906 creator A5081549752 @default.
• W4210372906 creator A5082513352 @default.
• W4210372906 creator A5084682660 @default.
• W4210372906 creator A5090223417 @default.
• W4210372906 creator A5090263108 @default.
• W4210372906 date "2022-08-01" @default.
• W4210372906 modified "2023-10-18" @default.
• W4210372906 title "Arabin pessary to prevent adverse perinatal outcomes in twin pregnancies with a short cervix: a multicenter randomized controlled trial (PESSARONE)" @default.
• W4210372906 cites W1862388756 @default.
• W4210372906 cites W2065974896 @default.
• W4210372906 cites W2072563758 @default.
• W4210372906 cites W2073347270 @default.
• W4210372906 cites W2134843796 @default.
• W4210372906 cites W2165272000 @default.
• W4210372906 cites W2165923451 @default.
• W4210372906 cites W2180466195 @default.
• W4210372906 cites W2186430820 @default.
• W4210372906 cites W2587005488 @default.
• W4210372906 cites W2768850026 @default.
• W4210372906 cites W3004085610 @default.
• W4210372906 cites W3135363943 @default.
• W4210372906 cites W3138680213 @default.
• W4210372906 cites W3141332331 @default.
• W4210372906 cites W3157456468 @default.
• W4210372906 cites W4376595483 @default.
• W4210372906 doi "https://doi.org/10.1016/j.ajog.2022.01.038" @default.
• W4210372906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35123930" @default.
• W4210372906 hasPublicationYear "2022" @default.
• W4210372906 type Work @default.
• W4210372906 citedByCount "4" @default.
• W4210372906 countsByYear W42103729062022 @default.
• W4210372906 countsByYear W42103729062023 @default.
• W4210372906 crossrefType "journal-article" @default.
• W4210372906 hasAuthorship W4210372906A5000904276 @default.
• W4210372906 hasAuthorship W4210372906A5001650037 @default.
• W4210372906 hasAuthorship W4210372906A5006946714 @default.
• W4210372906 hasAuthorship W4210372906A5021787063 @default.
• W4210372906 hasAuthorship W4210372906A5022386988 @default.
• W4210372906 hasAuthorship W4210372906A5029642865 @default.
• W4210372906 hasAuthorship W4210372906A5037923520 @default.
• W4210372906 hasAuthorship W4210372906A5047407744 @default.
• W4210372906 hasAuthorship W4210372906A5048730761 @default.
• W4210372906 hasAuthorship W4210372906A5048837610 @default.
• W4210372906 hasAuthorship W4210372906A5052004467 @default.
• W4210372906 hasAuthorship W4210372906A5052824216 @default.
• W4210372906 hasAuthorship W4210372906A5056903822 @default.
• W4210372906 hasAuthorship W4210372906A5059256161 @default.
• W4210372906 hasAuthorship W4210372906A5059769437 @default.
• W4210372906 hasAuthorship W4210372906A5062343791 @default.
• W4210372906 hasAuthorship W4210372906A5064528607 @default.
• W4210372906 hasAuthorship W4210372906A5073048018 @default.
• W4210372906 hasAuthorship W4210372906A5078240991 @default.
• W4210372906 hasAuthorship W4210372906A5078408177 @default.
• W4210372906 hasAuthorship W4210372906A5081549752 @default.
• W4210372906 hasAuthorship W4210372906A5082513352 @default.
• W4210372906 hasAuthorship W4210372906A5084682660 @default.
• W4210372906 hasAuthorship W4210372906A5090223417 @default.
• W4210372906 hasAuthorship W4210372906A5090263108 @default.
• W4210372906 hasBestOaLocation W42103729061 @default.
• W4210372906 hasConcept C121608353 @default.
• W4210372906 hasConcept C126322002 @default.
• W4210372906 hasConcept C131872663 @default.
• W4210372906 hasConcept C141071460 @default.
• W4210372906 hasConcept C168563851 @default.
• W4210372906 hasConcept C187212893 @default.
• W4210372906 hasConcept C2775953899 @default.
• W4210372906 hasConcept C2775965419 @default.
• W4210372906 hasConcept C2777740455 @default.
• W4210372906 hasConcept C2778376644 @default.
• W4210372906 hasConcept C2778384902 @default.
• W4210372906 hasConcept C2778721537 @default.
• W4210372906 hasConcept C2779234561 @default.
• W4210372906 hasConcept C2779303187 @default.
• W4210372906 hasConcept C2779918416 @default.
• W4210372906 hasConcept C2908647359 @default.
• W4210372906 hasConcept C2909855057 @default.

• next